MTNB vs TT · rev $1.1M vs P/E 36, rev $21.32B
Matinas BioPharma Holdings Inc (MTNB) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
MTNB currently screens at market cap $5.6M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the MTNB and TT stock pages for the full models.
Not investment advice.